KrishnaARaoMD
Oncology • Springfield, ILAssociate Professor, Internal Medicine, Southern Illinois University School of Medicine
Dr. Rao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
415 N 9th St
Springfield, IL 62702Phone+1 217-545-5817Fax+1 217-545-7021
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 1994 - 1997
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1991 - 1994
University of Miami Leonard M. Miller School of MedicineClass of 1991
Certifications & Licensure
IL State Medical License 2002 - 2026
FL State Medical License Active through 2014
MN State Medical License 1992 - 1994- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma Start of enrollment: 2010 Apr 15
- Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity Start of enrollment: 2010 Dec 01
- Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery Start of enrollment: 2011 Jun 20
- Join now to see all
Publications & Presentations
PubMed
- Quality of life following treatment with intra-arterial cisplatin with concurrent radiation and erlotinib for locally advanced head and neck cancer.Ricardo Cossyleon, Kathy Robinson, Kristin Delfino, K Thomas Robbins, Krishna Rao
Supportive Care in Cancer. 2024-01-09 - Loss of RAB25 Cooperates with Oncogenes in the Transformation of Human Mammary Epithelial Cells (HMECs) to Give Rise to Claudin-Low Tumors.Pooja Joshi, Vijayalakshmi Ayyagari, Samikshya Kandel, Vishnu Modur, Muhammad F Iqbal
Biomed Research International. 2024-01-01 - Impact of cytotoxic chemotherapy on aldo-keto reductase family 1 member B10 expression.Kathy Robinson, Zhe Cao, Kristin Delfino, Deliang Cao, Krishna Rao
The Journal of International Medical Research. 2023-06-01
Press Mentions
Illinois University to Begin New Cancer Specialist TrainingFebruary 18th, 2019
Illinois University to Begin New Cancer Specialist TrainingFebruary 17th, 2019
Professional Memberships
- Member
Other Languages
- Kannada
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
